___

• [1] (2006). What you need to know about cancer, (NIH Publication National Cancer Institute).
• [2] Blanchard, T., Srivastava, P.K., and Duan, F. (2013). Vaccines against advanced melanoma. Clinics in Dermatology 31, 179-190.
• [3] Lee, C., Collichio, F., Ollila, D., and Moschos, S. (2013). Historical review of melanoma treatment and outcomes. Clinics in Dermatology 31, 141-147.
• [4] Rajpar, S., and Marsden, J. (2008). ABC of skin cancer, Volume 140, (BMJ Books).
• [5] Health, N.I.o. (1988). In National Cancer Institute.
• [6] Skin Cancer Foundation. Melanoma Warning Signs and Images. Available from: http://www.skincancer.org/skin-cancer-information/melanoma [Erişim tarihi;01.12.2011].
• [7] Kaufman, H.L. (2005). The melanoma book: a complete guide to prevention and treatment, (Gotham).
• [8] Winslow, T (2008) National Cancer Institute at the National Institutes of Health. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/melanoma/Patient/page2 [Erişim tarihi;10.11.2011].
• [9] Özçelik, S., and Akyol, M. (2007). Melanoma Epidemiyolojisi. TURKDERM 41, 5.
• [10] Kızılbey, K. (2012). Melanoma hastalığını oluşturan sentetik peptidlerin poliakrilikasit ve kopolimerleri ile konjugasyonu. In Biochemistry. (İstanbul: Yildiz Technical University).
• [11] International Agency for Research on Cancer, World Health Organisation. Available from: http://globocan.iarc.fr/ [Erişim tarihi;03.12.2011].
• [12] Clark, J.R., and March, J.B. (2006). Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends in biotechnology 24, 212-218.
• [13] Gurunathan, S., Klinman, D.M., and Seder, R.A. (2000). DNA vaccines: immunology, application, and optimization*. Annual review of immunology 18, 927-974.
• [14] Coates, T., Wilson, R., Patrick, G., André, F., and Watson, V. (2001). Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clinical therapeutics 23, 392-403.
• [15] Moĭsa, A., and Kolesanova, E. (2010). [Synthetic peptide vaccines]. Biomeditsinskaia khimiia 57, 14-30.
• [16] Magliani, W., Conti, S., Salati, A., Arseni, S., Ravanetti, L., Frazzi, R., and Polonelli, L. (2003). Biotechnological approaches to the production of idiotypic vaccines and antiidiotypic antibiotics. Current Pharmaceutical Biotechnology 4, 91-97.
• [17] Barrios, Y., Cabrera, R., Yáñez, R., Briz, M., Plaza, A., Forés, R., Fernández, M.-N., and Díaz-Espada, F. (2002). Anti-idiotypic vaccination in the treatment of low-grade B-cell lymphoma. haematologica 87, 400-407.
• [18] Akan, E. (1992). Genel Mikrobiyoloji ve İmmünoloji. Güney Matbaası, Adana.
• [19] Bilgehan, H. (1993). Temel Mikrobiyoloji ve Bağışıklık Bilimi, (İzmir: Barış Yayınları, Fakülteler Kitapevi).
• [20] Yufeng, L., Shujuan, L., Kim, M., and Patrick, H. Summary of the primer on tumor immunology and the biological therapy of cancer. Journal of Translational Medicine 7.
• [21] Laino, C. (2009). Experimental Vaccine Improves Response in Melanoma. Oncology Times 31, 39.
• [22] Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X.O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N.P., Overwijk, W.W., and Dong, C. (2009). T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31, 787-798.
• [23] Mustafaev, M., and Norimov, A.S. (1990). Polymer-metal complexes of protein antigens--new highly effective immunogens. Biomedical science 1, 274.
• [24] Mustafaev, M.I. (1996). Biyopolimerler, (Marmara Araştırma Merkezi).
• [25] Mustafaev, M. (2004). Functionally Biopolymer Systems. Sigma Journal of Engineering and Natural Science 4, 1-201.
• [26] Petrov, R., Mustafaev, M., and Norimov, A.S. (1992). Physico-chemical criteria for the construction of artificial immunomodulators and immunogens on the basis of polyelectrolyte complexes. Vol 4, 1-113.
• [27] Anderson, K.S., and LaBaer, J. (2005). The sentinel within: exploiting the immune system for cancer biomarkers. J Proteome Res 4, 1123-1133.
• [28] Chen, Q., Jackson, H., Shackleton, M., Parente, P., Hopkins, W., Sturrock, S., MacGregor, D., Maraskovsky, E., Tai, T.Y., Dimopoulos, N., et al. (2005). Characterization of antigen-specific CD8+ T lymphocyte responses in skin and peripheral blood following intradermal peptide vaccination. Cancer Immun 5, 5.
• [29] Davis, I.D. (2000). An overview of cancer immunotherapy. Immunol Cell Biol 78, 179-195.
• [30] Ge, H.L., Wang, Y., Wang, S.J., and Zhang, Y. (2006). Identification of melanoma-specific peptide epitopes by HLA-A2.1-restricted cytotoxic T lymphocytes. Acta Biochim Biophys Sin (Shanghai) 38, 110-118.
• [31] Jager, E., Gnjatic, S., Nagata, Y., Stockert, E., Jager, D., Karbach, J., Neumann, A., Rieckenberg, J., Chen, Y.T., Ritter, G., et al. (2000). Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci U S A 97, 12198-12203.
• [32] Smith, C., and Cerundolo, V. (2001). Immunotherapy of melanoma. Immunology 104, 1-7.
• [33] Anderson, K.S., and LaBaer, J. (2005). The sentinel within: Exploiting the immune system for cancer biomarkers. J Proteome Res 4, 1123-1133.
• [34] Nestle, F. (2002). Vaccines and melanoma. Clinical and experimental dermatology 27, 597-601.
• [35] Basalp, A., Bermek, E., Cirakoglu, B., Coka, V., Mustafaev, M.I., and Sarac, A.S. (1996). Immune response to 17 beta-estradiol in polyelectrolyte complex: antigen specificity and affinity of hybridoma clones. Hybridoma 15, 233-238.
• [36] Basalp, A., Mustafaeva, Z., Mustafaev, M., and Bermek, E. (2000). Immune response to 17beta-estradiol involved in polymer gels: antigen specificity and affinity of hybridoma clones. Hybridoma 19, 495-499.
• [37] Basalp, A., Mustafaeva, Z., and Mustafaev, M. (2002). Immunogenic Cu2+-induced biopolymer systems comprising a steroid hormone, protein antigen, and synthetic polyelectrolytes. Hybrid Hybridomics 21, 45-51.
• [38] Berezin, I.V., Mustafaev, M. I., Dikov, M. M., Egorov, A. M. (1980). Methods of preparation of stabile enzymes, containing SH- groups.
• [39] Chegel, V., Shirshov, Y., Avilov, S., Demchenko, M., and Mustafaev, M. (2002). A novel aldehyde dextran sulfonate matrix for affinity biosensors. J Biochem Biophys Methods 50, 201-216.
• [40] Chegel, V., Shirshov, Y., Avilov, S., Verevka, S., Demchenko, M., and Mustafaev, M. (2000). Oxidized polysaccharides as matrix structures for surface plasmon resonance biosensors. Functional materials 7, 1.
• [41] Abuchowski, A., Van Es, T., Palczuk, N., and Davis, F. (1977). Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. Journal of Biological Chemistry 252, 3578.
• [42] Dilgimen, A.S., Mustafaeva, Z., Demchenko, M., Kaneko, T., Osada, Y., and Mustafaev, M. (2001). Water-soluble covalent conjugates of bovine serum albumin with anionic poly(N-isopropyl-acrylamide) and their immunogenicity. Biomaterials 22, 2383-2392.
• [43] Dincer, B., Mustafaev, M., and Bayuelken, S. (1997). High‐performance liquid chromatography study of water‐soluble ternary polyacrylamide‐metal‐protein complexes. J Appl Polym Sci 65, 37-40.
• [44] Filenko, A., Demchenko, M., Mustafaeva, Z., Osada, Y., and Mustafaev, M. (2001). Fluorescence study of Cu2+-induced interaction between albumin and anionic polyelectrolytes. Biomacromolecules 2, 270-277.
• [45] Güney, O., Saraq, A.S., and Mustafaev, M.I. (1997). Fluorescence and turbidimetry study of complexation of human serum albumin with polycations. Journal of bioactive and compatible polymers 12, 231.
• [46] Kabanov, V.A., Mustafaev, M.I., Nekrasov, A.V., Norimov, A., and Petrov, R.V. (1984). [Critical nature of the effect of the degree of polyelectrolyte polymerization on immunostimulating properties]. Dokl Akad Nauk SSSR 274, 998-1001.
• [47] Mustafaev, M., Osada, Y., Matsukata, M., Basalp, A., Ēirakoglu, B., and Bermek, E. (1996). New amphiphilic immunogens by poly (N-Isopropylacrylamide)-modified bovine serum albumin. Polymer Gels and Networks 4, 363-372.
• [48] Mustafaev, M.I. (1996). Polyelectrolytes in Immunology: Fundametals and Perspectives. Turkish Journal of Chemistry 20, 126-138.
• [49] Mustafaev, M., and Saraç, A. (1996). Polyelectrolyte complexes (in immunology). The Polymeric Materials. Encyclopedia. Synthesis, Properties and Applications, JC Salomone, ed., CRC Press Inc., Boca Raton, FL, 5771-5777.
• [50] Mustafaev, M., Bayülken, S., Ergen, E., Yılmaz Erkol, A., and Ardagil, N. (2001). Radiation-induced formation of polyacrylic acid–protein covalent conjugates. Radiation Physics and Chemistry 60, 567-575.
• [51] Mustafaev, M., Mustafaeva, Z., Ergen, E., Uraki, Y., and Sano, Y. (2002). Novel betulin- containing polyelectrolyte Conjugates. Journal of bioactive and compatible polymers 17, 251.
• [52] Mustafaev, M., and Mustafaeva, Z. (2002). Novel polypeptide-comprising biopolymer systems. Technology and Health Care-Journal of the European Society for Engineering and Medicine 10, 217-226.
• [53] Özeroglu, C., Namazova, N., Mustafaev, M., and Saraç, A. (1996). The complex formation between polyacrylamide containing glycine end groups and bovine serium albumin in the presence of copper (II) in neutral aqueous media. Colloid & Polymer Science 274, 418-427.
• [54] Oezeroğlu, C., Gueney, O., Sarac, A.S., and Mustafaev, M.I. (1996). The polymerization of acrylamide initiated with CE (IV) and KMNO4 redox systems in the presence of glycine. J Appl Polym Sci 60, 759-765.
• [55] Yücel, F., Çirakoglu, B., Mustafaeva, Z., and Mustafaev, M. (2001). Immune Response to Progesterone Immobilized on Cu2+-Induced Amphifilic Polyelectrolyte-Protein Complex: Antigen Specificity and Affinity of Hybridoma Clones. Hybridoma 20, 11-15.
• [56] Hermanson, G.T. (1996). Bioconjugate techniques, (Academic Press).
• [57] Sheehan, J., Cruickshank, P., and Boshart, G. (1961). Notes-A Convenient Synthesis of Water-Soluble Carbodiimides. The Journal of Organic Chemistry 26, 2525-2528.
• [58] Sheehan, J.C., Preston, J., and Cruickshank, P.A. (1965). A rapid synthesis of oligopeptide derivatives without isolation of intermediates. Journal of the American Chemical Society 87, 2492-2493.
• [59] Chu, F.S., Chang, F.C., and Hinsdill, R.D. (1976). Production of antibody against ochratoxin A. Appl Environ Microbiol 31, 831-835.
• [60] Chu, F.S., and Ueno, I. (1977). Production of antibody against aflatoxin B1. Appl Environ Microbiol 33, 1125-1128.